Septerna, Inc. · NASDAQ:SEPN
Long Daniel D. sold 15,000 Septerna, Inc. shares (Form 4)
Traded Jun 22, 2026 · Filed Jun 24, 2026
On Jun 22, 2026, Long Daniel D. (SVP, Drug Discovery) sold 15,000 Septerna, Inc. shares at an average US$35.51 for US$533K under a trading plan, leaving 96,412 shares. Filed Jun 24, 2026 (Form 4).
- Sold
- 15,000 shares
- Price
- US$35.51 average (US$35.10 to US$35.97)
- Value
- US$533K
- Holding after
- 96,412 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- SVP, Drug Discovery
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | Option exercise | 10,529 | US$2.76 | 106,941 | Direct |
| Jun 22, 2026 | Common Stock | Option exercise | 4,471 | US$11.70 | 111,412 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 8,000 | US$35.10 | 103,412 | Direct |
| Jun 22, 2026 | Common Stock | Sale | 7,000 | US$35.97 | 96,412 | Direct |
Source
Related
- Septerna, Inc.
- Long Daniel D.
- Septerna, Inc. shareholders
- Form 4 · Long Daniel D. · Sep 3, 2026
- Form 4 · Long Daniel D. · Aug 5, 2026
- Form 4 · Long Daniel D. · Jul 2, 2026
- Form 4 · Third Rock Ventures GP VI, L.P. · Aug 14, 2026
- Form 4 · Shah Rajeev M. · Aug 14, 2026
- Schedule 13G/A · Driehaus Capital Management LLC · Aug 14, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Bhatt Elizabeth · Aug 13, 2026